Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A comparison between open, semi-robotic and totally robotic surgery.
bladder cancer
ileal conduit
intracorporeal
radical cystectomy
robotic
Journal
The international journal of medical robotics + computer assisted surgery : MRCAS
ISSN: 1478-596X
Titre abrégé: Int J Med Robot
Pays: England
ID NLM: 101250764
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
22
12
2020
received:
12
11
2020
accepted:
29
12
2020
pubmed:
6
1
2021
medline:
21
7
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
It was aimed to compare open versus robotic-assisted radical cystectomy (RARC) with intracorporeal ileal conduit (ICIC), versus RARC with extracorporeal ileal conduit (ECIC) formation for bladder cancer. Open, RARC-ECIC and RARC-ICIC groups were compared in terms of patient demographics, operative and postoperative parameters, pathological parameters, complications and functional outcomes. Mean operative times were lower in the RARC-ECIC group (p = 0.004). Mean estimated blood loss was significantly lower (p < 0.01) in the robotic groups. The blood transfusion was lower in RARC-ICIC groups (p < 0.001). Rates of stage pT3-4 disease were the highest in the RARC-ICIC group (p = 0.004). LOS was significantly shorter in the RARC-ICIC group (p = 0.01). Numbers of Clavien 3-5 complications were lower in the robotic groups (p = 0.012). RARC and ICIC is a complex procedure involving an increased operation time but with the advantages of lower estimated blood loss, transfusion rates, complications and hospital stays compared with open surgery.
Sections du résumé
BACKGROUND
BACKGROUND
It was aimed to compare open versus robotic-assisted radical cystectomy (RARC) with intracorporeal ileal conduit (ICIC), versus RARC with extracorporeal ileal conduit (ECIC) formation for bladder cancer.
MATERIALS AND METHODS
METHODS
Open, RARC-ECIC and RARC-ICIC groups were compared in terms of patient demographics, operative and postoperative parameters, pathological parameters, complications and functional outcomes.
RESULTS
RESULTS
Mean operative times were lower in the RARC-ECIC group (p = 0.004). Mean estimated blood loss was significantly lower (p < 0.01) in the robotic groups. The blood transfusion was lower in RARC-ICIC groups (p < 0.001). Rates of stage pT3-4 disease were the highest in the RARC-ICIC group (p = 0.004). LOS was significantly shorter in the RARC-ICIC group (p = 0.01). Numbers of Clavien 3-5 complications were lower in the robotic groups (p = 0.012).
CONCLUSIONS
CONCLUSIONS
RARC and ICIC is a complex procedure involving an increased operation time but with the advantages of lower estimated blood loss, transfusion rates, complications and hospital stays compared with open surgery.
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2221Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Lobo N, Thurairaja R, Nair R, Dasgupta P, Khan MS. Robot-assisted radical cystectomy with intracorporeal urinary diversion - the new 'gold standard'? Evidence from a systematic review. Arab J Urol. 2018;16(3):307-313.
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164-174.
Aziz A, May M, Burger M, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol. 2014;66(1):156-163.
Roghmann F, Sukumar S, Ravi P, et al. Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care. Urol Int. 2014;92(1):27-34.
Taylor JM, Feifer A, Savage CJ, et al. Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU Int. 2012;109(6):855-859.
Collins JW, Wiklund NP. Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes. BJU Int. 2014;114(3):326-333.
Khan MS, Omar K, Ahmed K, et al. Long-term oncological outcomes from an early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol. 2020;77(1):110-118.
Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus ORC in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018;391(10139):2525-2536.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.
Canda AE, Atmaca AF, Altinova S, Akbulut Z, Balbay MD. Robot assisted laparoscopic nerve sparing radical cystectomy with bilateral extended lymph node dissection and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases. BJU Int. 2012;110(3):434-444.
Akbulut Z, Canda AE, Ozcan MF, Atmaca AF, Ozdemir AT, Balbay MD. Robot assisted laparoscopic nerve sparing radical cystoprostatectomy with bilateral extended lymph node dissection and intracorporeal Studer pouch construction: outcomes of first 12 cases. J Endourol. 2011;25(9):1469-1479.
Atmaca AF, Canda AE, Gok B, Akbulut Z, Altinova S, Balbay MD. Open versus robotic radical cystectomy with intracorporeal Studer diversion. J Soc Laparoendosc Surg. 2015;19:e2014.
Hautmann RE, Abol-Enein H, Lee CT, et al. Urinary diversion: how experts divert. Urology. 2015;85(1):233-238.
Gok B, Atmaca AF, Canda AE, et al. Robotic radical cystectomy with intracorporeal studer pouch formation for bladder cancer: experience in ninety-eight cases. J Endourol. 2019;33(5):375-382.
Hussein AA, May PR, Jing Z, et al. Outcomes of intracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International robotic cystectomy Consortium. J Urol. 2018;199(5):1302.
Skinner EC, Stein JP, Skinner DG. Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol. 2007;25(1):66-71.
Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170(1):35-41.
Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22(14):2781-2789.
Bochner BH, Dalbagni G, Sjoberg DD, et al. Comparing open radical cystectomy and robot assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol. 2015;67:1042-1050.
Parekh D. Pnflba-18: a prospective, multicenter, randomized trial of open versus robotic radical cystectomy (RAZOR). J Urol. 2017;197:e918.
Simone G, Papalia R, Misuraca L, et al. Robotic intracorporeal padua ileal bladder: surgical technique, perioperative, oncologic and functional outcomes. Eur Urol. 2018;73(6):934-940. https://doi.org/10.1016/j.eururo.2016.10.018.
Brassetti A, Cacciamani G, Anceschi U, et al. Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study. World J Urol. 2020;38(4):837-843. https://doi.org/10.1007/s00345-019-02842-3.
Simone G, Tuderti G, Misuraca L, et al. Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series. Eur J Surg Oncol. 2018;44(9):1432-1438. https://doi.org/10.1016/j.ejso.2018.04.006.
Collins JW, Hosseini A, Adding C, et al. Early recurrence patterns following totally intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic Urology Section (ERUS) Scientific Working Group. Eur Urol. 2017;71(5):723-726.
Zhang JH, Ericson KJ, Thomas LJ, et al. Large single institution comparison of perioperative outcomes and complications of open radical cystectomy, intracorporeal robot-assisted radical cystectomy and robotic extracorporeal approach. J Urol. 2019;203(3):512-521.
Azzouni FS, Din R, Rehman S, et al. The first 100 consecutive, robot-assisted, intracorporeal ileal conduits: evolution of technique and 90-day outcomes. Eur Urol. 2013;63(4):637-643.
Bertolo R, Agudelo J, Garisto J, et al. Perioperative outcomes and complications after robotic radical cystectomy with intra-corporeal or extra-corporeal ileal conduit urinary diversion: Head-to-head comparison from a single-institutional prospective study. Urology. 2019;129:98-105.
Novara G, Catto JW, Wilson T, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol. 2015;67(3):376-401.
Bochner BH, Dalbagni G, Sjoberg DD, et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol. 2015;67(6):1042-1050.
Matsumoto K, Tabata KI, Hirayama T, et al. Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: perioperative outcomes of a single-center experience. Asian J Surg. 2019;42(1):189-196.
Thress TM, Cookson MS, Patel S. Robotic cystectomy with intracorporeal urinary diversion: review of current techniques and outcomes. Urol Clin North Am. 2018;45(1):67-77.
Gudjo'nsson S, Davidsson T, Mansson W. Incontinent urinary diversion. BJU Int. 2008;102(9):1320-1325.
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164-174.
Tuderti G, Mastroianni R, Brassetti A, et al. Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes. Minerva Urol Nefrol. 2020. https://doi.org/10.23736/S0393-2249.20.03948-X.